Clinical courses and predictors for rebleeding in patients with peptic ulcers and non-bleeding visible vessels: a prospective study.

H J Lin, C L Perng, F Y Lee, C H Lee, S D Lee

Department of Medicine, Veterans General Hospital-Taipei, Taiwan, ROC.

Detailed characterisation of non-bleeding visible vessels in terms of colour, size evolution, and time of rebleeding is important in determining the natural history of these lesions. The colour and size of non-bleeding visible vessels were observed endoscopically every day for three days and then every other day until rebleeding or flattening of visible vessels occurred in 140 patients. Rebleeding happened in 61 (44%) patients. Of them, 59 (97%) rebled within 72 hours. Flattening of visible vessels happened in 79 (56%) patients and 77 of 79 (98%) had flattening of visible vessels within 72 hours. Rebleeding rate increased with increasing length of exposed vessels (r = 0.96, p < 0.001). Coffee ground fluid or blood retention in the stomach and ulcer size > or = 2.0 cm were independent predictors for rebleeding using multivariate analysis. It is suggested that patients with non-bleeding visible vessels and independent predictors for rebleeding may need early aggressive treatment.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• CHIU, Y.-C., WU, K.-L., KUO, C.-H., HU, T.-H., CHOU, Y.-P., CHUAH, S.-K., KUO, C.-M., KEE, K.-M., CHANGCHIEN, C.-S., LIU, J.-W., CHIU, K.-W. (2005). ENDOSCOPIC FINDINGS AND MANAGEMENT OF DENGUE PATIENTS WITH UPPER GASTROINTESTINAL BLEEDING. Am J Trop Med Hyg 73: 441-444 [Abstract] [Full Text]  
• Barkun, A., Bardou, M., Marshall, J. K., for the Nonvariceal Upper GI Bleeding Consensus Co, (2003). Consensus Recommendations for Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding. ANN INTERN MED 139: 843-857 [Abstract] [Full Text]  
• Lin, H.-J., Lo, W.-C., Lee, F.-Y., Perng, C.-L., Tseng, G.-Y. (1998). A Prospective Randomized Comparative Trial Showing That Omeprazole Prevents Rebleeding in Patients With Bleeding Peptic Ulcer After Successful Endoscopic Therapy. Arch Intern Med 158: 54-58 [Abstract] [Full Text]